ROCKLATAN (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%

Serial Number 88293353
606

Registration Progress

Application Filed
Feb 7, 2019
Under Examination
Aug 6, 2019
Approved for Publication
Jun 11, 2019
Published for Opposition
Jun 11, 2019
Registered

Trademark Image

ROCKLATAN (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%

Basic Information

Serial Number
88293353
Filing Date
February 7, 2019
Published for Opposition
June 11, 2019
Abandonment Date
March 9, 2020
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 9, 2020
Classes
005

Rights Holder

Aerie Pharmaceuticals, Inc.

03
Address
550 Hills Drive, 3rd Floor
Bedminster, NJ 07921

Ownership History

Aerie Pharmaceuticals, Inc.

Original Applicant
03
Bedminster, NJ

Aerie Pharmaceuticals, Inc.

Owner at Publication
03
Bedminster, NJ

Legal Representation

Attorney
Melissa W. Woo-Allen

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Mar 9, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 9, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 6, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 11, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 22, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2019 ALIE A ASSIGNED TO LIE Loading...
Apr 22, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 19, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 19, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 19, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 19, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 1, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of glaucoma and hypertension
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word "ROCKLATAN" in lower case block letters with "ROCK" in a darker shade than "LATAN" with the words "NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION" in parentheses followed by "0.02%/0.005%" beneath the word "ROCKLATAN".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%"